Oct 01, 2021 · Malignant neoplasm of ascending colon. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. C18.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C18.2 became effective on October 1, 2021.
Oct 01, 2021 · 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. C18.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C18.9 became effective on October 1, 2021. This is the American ICD-10-CM version of C18.9 - other international versions of ICD-10 C18.9 may differ.
ICD-10-CM Diagnosis Code C18.6 [convert to ICD-9-CM] Malignant neoplasm of descending colon. Adenocarcinoma, descending colon; Cancer of the colon, descending; Primary adenocarcinoma of descending colon; Primary malignant neoplasm of descending colon. ICD-10-CM Diagnosis Code C18.6.
Cancer, right leg; Leg cancer, bilateral legs; Primary malignant neoplasm of bilateral lower limbs; Primary malignant neoplasm of right lower limb. ICD-10-CM Diagnosis Code C76.51. Malignant neoplasm of right lower limb. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code.
Diagnosis | ICD-9 code | ICD-10 code |
---|---|---|
Colon unspecified | 153.9 | C18.9 |
Malignant neoplasm of appendix vermiformis | 153.5 | N/A |
Malignant neoplasm of appendix | N/A | C18.1 |
Malignant neoplasm of other specified sites of large intestine | 153.8 | N/A |
Malignant neoplasm of colon. Approximate Synonyms. Cancer of the colon. Cancer of the colon, adenocarcinoma. Cancer of the colon, hereditary nonpolyposis. Cancer of the colon, stage 1. Cancer of the colon, stage 2. Cancer of the colon, stage 3. Cancer of the colon, stage 4.
A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma.
Malignant tumor of colon. Metastasis from malignant tumor of colon. Primary adenocarcinoma of colon. Clinical Information. A primary or metastatic malignant neoplasm involving the colon. A primary or metastatic malignant neoplasm that affects the colon or rectum.
The 2022 edition of ICD-10-CM C18.9 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C18.4 became effective on October 1, 2021.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C18.0 became effective on October 1, 2021.
Cancer of the cecum. Cancer of the cecum, adenocarcinoma. Primary malignant neoplasm of cecum. Primary malignant neoplasm of ileocecal valve. Clinical Information. A primary or metastatic malignant neoplasm that affects the cecum. Representative examples include carcinoma, lymphoma, and sarcoma.
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ). A primary or metastatic malignant neoplasm that affects the cecum. Representative examples include carcinoma, lymphoma, and sarcoma.
Colorectal cancer (also known as colon cancer, rectal cancer, or bowel cancer) is the development of cancer in the colon or rectum (parts of the large intestine). It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, ...
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
The neoplasm table in the Alphabetic Index should be referenced first. However, if the histological term is documented, that term should be referenced first, rather than going immediately to the Neoplasm Table, in order to determine which column in the Neoplasm Table is appropriate. Alphabetic Index to review the entries under this term and the instructional note to “see also neoplasm, by site, benign.” The table provides the proper code based on the type of neoplasm and the site. It is important to select the proper column in the table that corresponds to the type of neoplasm. The Tabular List should then be referenced to verify that the correct code has been selected from the table and that a more specific site code does not exist.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
When the reason for admission/encounter is to determine the extent of the malignancy, or for a procedure such as paracentesis or thoracentesis, the primary malignancy or appropriate metastatic site is designated as the principal or first-listed diagnosis, even though chemotherapy or radiotherapy is administered.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .